… ProQR to Present at the JMP Securities Life Sciences … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
Call on July 20 will include a snapshot from the ongoing InSight open-label extension study of sepofarsen, including preliminary second eye treatment data
… ProQR Strengthens Leading Intellectual Property Estate for … (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through … and Trademark Office (USPTO) granted a new patent to ProQR, under US patent No. 11,781,134 that relates to a …
… ProQR Announces Annual General Meeting of Shareholders and … & CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a …
… ProQR Announces Results for the Fourth Quarter and Full Year … and full year 2015. “2015 was a year of execution for ProQR. From the inception of ProQR in 2012, we had been … study is also assessing sweat chloride, weight gain, CFQ-R Respiratory Symptom Score and lung function, measured by …
… ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023 LEIDEN, Netherlands & CAMBRIDGE, … (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through …
… ProQR Supports Rare Disease Day 2018 and Honors Henri A. … the legacy of the late Henri A. Termeer, co-founder of ProQR, being held on the same day in Boston, MA. Henri … Genzyme and a visionary and pioneer for rare diseases, was ProQR’s co-founder in 2012 and vice chairman of the …
… ProQR Announces Webcast of Presentation at Upcoming HC … will be accessible from the “Investors & Media” section of ProQR’s website ( www.proqr.com ) under ‘Events’, beginning January 11, 2021. …